Current and Emerging Targets in Immunotherapy for Osteosarcoma

Osteosarcoma is the most common primary malignancy of bone. Although outcomes of patients with osteosarcoma have improved since the introduction of chemotherapy, outcomes of metastatic or unresectable osteosarcomas are still unsatisfactory. To improve osteosarcoma outcomes, the development of novel...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Oncol
Egile Nagusiak: Miwa, Shinji, Shirai, Toshiharu, Yamamoto, Norio, Hayashi, Katsuhiro, Takeuchi, Akihiko, Igarashi, Kentaro, Tsuchiya, Hiroyuki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2019
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332920/
https://ncbi.nlm.nih.gov/pubmed/30693030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7035045
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak